NEW HAMPSHIRE — Patients For Affordable Drugs Now kicks off a campaign today thanking Rep. Chris Pappas (NH-01) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Granite Staters. The campaign includes digital ads as well as grassroots advocacy, in which constituents will contact Rep. Pappas to thank him for fighting for patients. The campaign comes after Big Pharma launched attack ads loaded with lies, pressuring Rep. Pappas not to support H.R. 3.
“Big Pharma is trying to get Rep. Pappas to bow to its power with lies and fear-mongering. But he is standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Rep. Pappas’s leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign launches with an ad highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ad will run on digital platforms in New Hampshire’s first district.
You can watch the ad here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The New Hampshire campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.